Pittsburgh, PA, United States of America

Isis J Amaye

This inventor holds 1 USPTO granted patent and 4 published patent applications. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isis J Amaye. Retrieved from https://idiyas.com/inventor/isis-j-amaye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Isis J Amaye: Inventor of a KV7 Channel Activator Patent

Introduction

Isis J Amaye is a woman inventor associated with Pittsburgh, Pennsylvania. Her patent work concerns pyrazolyl compounds designed to activate KV7 channels, a focus with potential applications in treating neurological and other disorders.

Latest Patents

The provided information lists one patent for Amaye: “Pyrazolyl Compounds as KV7 Channel Activators.” The patent describes optionally substituted pyrazolylacetamides, pharmaceutical compositions containing these compounds, and methods for using them to treat conditions including epilepsy, amyotrophic lateral sclerosis, pain, hyperexcitability, dyskinesia, dystonia, mania, tinnitus, neurodevelopmental disorders, smooth muscle contractility disorders, Dravet syndrome, and posttraumatic stress disorder. Her listed patent portfolio comprises 1 patent.

Career Highlights

Amaye’s listed invention brings together medicinal chemistry and potential therapeutic applications. The patent describes compounds intended to activate KV7 channels and outlines their possible use in pharmaceutical compositions and disease-treatment methods.

Collaborations

The provided information names James S. Hale and David A. Mareska as Amaye’s coworkers. Their inclusion points to a collaborative context for the patent work, though specific roles or contributions are not provided.

Conclusion

Isis J Amaye’s listed patent centers on pyrazolyl compounds as KV7 channel activators and describes potential applications across a range of disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…